Skip to main content
Signal8
Akinsanya Karen profile photo

Karen Akinsanya

CIK: 0001797672

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (43.8%)

Position reduction

Option Exercises (M)3 (18.8%)

Derivative conversions

Awards (A)6 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Schrodinger, Inc. logo
SDGR

Schrodinger, Inc.

Officer
Nautilus Biotechnology, Inc. logo
NAUT

Nautilus Biotechnology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Sep 17, 2026
    Exercise(M)
    Direct
    31.6K shares at avg. $4.34$137K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Sep 17, 2026
    Sale(S)
    Direct
    21.6K shares at avg. $30.00$648K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Sep 17, 2026
    Sale(S)
    Direct
    10K shares at avg. $28.00$280K
  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    Jun 18, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    45K shares-
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Mar 5, 2026
    Sale(S)
    Direct
    1.4K shares at avg. $12.90$18K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Mar 2, 2026
    Sale(S)
    Direct
    2.2K shares at avg. $11.99$26K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Mar 2, 2026
    Award(A)
    Direct
    27.6K shares-
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Mar 2, 2026
    Award(A)
    Direct
    6.1K shares-
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Mar 2, 2026
    Award(A)
    Direct
    24.3K shares-
  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    Jun 23, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    45K shares-
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Apr 14, 2025
    Exercise(M)
    Direct
    3.3K shares at avg. $2.92$10K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Apr 14, 2025
    Sale(S)
    Direct
    8.4K shares at avg. $25.11$210K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Apr 14, 2025
    Sale(S)
    Direct
    5K shares at avg. $25.11$126K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Apr 14, 2025
    Sale(S)
    Direct
    3.3K shares at avg. $25.00$84K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Apr 14, 2025
    Exercise(M)
    Direct
    13.4K shares at avg. $3.22$43K
  • Schrodinger, Inc. logo
    SDGR

    Schrodinger, Inc.

    Mar 3, 2025
    Award(A)
    Direct
    15.6K shares-

1-16 of 16

About Akinsanya Karen

Akinsanya Karen (SEC CIK 0001797672) files insider reports with the SEC as Officer of Schrodinger, Inc. (SDGR) and Director of Nautilus Biotechnology, Inc. (NAUT).

Signal8 holds 7 ownership filings by Akinsanya Karen, all Form 4s, filed between Mar 4, 2025 and Sep 21, 2026. Those filings report 16 transactions, from Mar 3, 2025 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Akinsanya Karen's filings is in NEW YORK, NY.

Recent filings by Akinsanya Karen

  • Sep 17, 2026: Option exercise of SDGR shares (Form 4, code M).
  • Sep 17, 2026: Open-market sales of SDGR shares (2 lines, Form 4, code S).
  • Jun 18, 2026: Grant or award of NAUT derivative securities (Form 4, code A).
  • Mar 5, 2026: Open-market sale of SDGR shares (Form 4, code S).
  • Mar 2, 2026: Open-market sale of SDGR shares (Form 4, code S).

Other insiders filing for Schrodinger, Inc. (SDGR)

How to read Form 4 transaction codes